Differential Anti-Glycan Antibody Responses in Schistosoma mansoni-Infected Children and Adults Studied by Shotgun Glycan Microarray

PLoS Neglected Tropical Diseases

Volumn 6, Issue 11, 2012, Pages

  van Diepen, Angela ^a   Smit, Cornelis H ^a   van Egmond, Loes ^a   Kabatereine, Narcis B ^b   Pinot de Moira, Angela ^c   Dunne, David W ^c   Hokke, Cornelis H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MINISTRY OF HEALTH   (Uganda)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGLYCAN ANTIBODY; GLYCOCONJUGATE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; CHILD; CONTROLLED STUDY; FECES ANALYSIS; FEMALE; HUMAN; MALE; MASS SPECTROMETRY; MICROARRAY ANALYSIS; NONHUMAN; PRESCHOOL CHILD; PROTEIN BINDING; PROTEIN MICROARRAY; PROTEIN SECRETION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SCHOOL CHILD; SHOTGUN GLYCAN MICROARRAY;

ADULT; AGE FACTORS; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; POLYSACCHARIDES; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; YOUNG ADULT;

EID: 84870746348     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001922     Document Type: Article

References (54)

1. Gryseels B, Polman K, Clerinx J, Kestens L, (2006) Human schistosomiasis. Lancet 368: 1106-1118.
2. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J, (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6: 411-425.
3. Fenwick A, Webster JP, (2006) Schistosomiasis: challenges for control, treatment and drug resistance. Curr Opin Infect Dis 19: 577-582.
4. Gray DJ, Ross AG, Li YS, McManus DP, (2011) Diagnosis and management of schistosomiasis. Br Med J 342: d2651.
5. Doenhoff MJ, Hagan P, Cioli D, Southgate V, Pica-Mattoccia L, et al. (2009) Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs. Parasitology 136: 1825-1835.
6. Melman SD, Steinauer ML, Cunningham C, Kubatko LS, Mwangi IN, et al. (2009) Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PLoS Negl Trop Dis 3: e504.
7. Utzinger J, N'goran EK, Caffrey CR, Keiser J, (2011) From innovation to application: Social-ecological context, diagnostics, drugs and integrated control of schistosomiasis. Acta Trop 120: S121-137.
8. Vereecken K, Naus CW, Polman K, Scott JT, Diop M, et al. (2007) Associations between specific antibody responses and resistance to reinfection in a Senegalese population recently exposed to Schistosoma mansoni. Trop Med Int Health 12: 431-444.
9. Fulford AJ, Butterworth AE, Sturrock RF, Ouma JH, (1992) On the use of age-intensity data to detect immunity to parasitic infections, with special reference to Schistosoma mansoni in Kenya. Parasitology 105: 219-227.
10. Ouma JH, Fulford AJ, Kariuki HC, Kimani G, Sturrock RF, et al. (1998) The development of schistosomiasis mansoni in an immunologically naive immigrant population in Masongaleni, Kenya. Parasitology 117: 123-132.
11. Butterworth AE, Fulford AJ, Dunne DW, Ouma JH, Sturrock RF, (1988) Longitudinal studies on human schistosomiasis. Philos Trans R Soc Lond B Biol Sci 321: 495-511.
12. Wilkins HA, Blumenthal UJ, Hagan P, Hayes RJ, Tulloch S, (1987) Resistance to reinfection after treatment of urinary schistosomiasis. Trans R Soc Trop Med Hyg 81: 29-35.
13. Leenstra T, Acosta LP, Wu HW, Langdon GC, Solomon JS, et al. (2006) T-helper-2 cytokine responses to Sj97 predict resistance to reinfection with Schistosoma japonicum. Infect Immun 74: 370-381.
14. Butterworth A, Dunne D, Fulford A, Capron M, Khalife J, et al. (1988) Immunity in human schistosomiasis mansoni: cross-reactive IgM and IgG2 anti-carbohydrate antibodies block the expression of immunity. Biochimie 70: 1053-1063.
15. Dunne DW, Butterworth AE, Fulford AJ, Kariuki HC, Langley JG, et al. (1992) Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur J Immunol 22: 1483-1494.
16. Hagan P, Blumenthal UJ, Dunn D, Simpson AJ, Wilkins HA, (1991) Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 349: 243-245.
17. Naus CW, van Dam GJ, Kremsner PG, Krijger FW, Deelder AM, (1998) Human IgE, IgG subclass, and IgM responses to worm and egg antigens in schistosomiasis haematobium: a 12-month study of reinfection in Cameroonian children. Clin Infect Dis 26: 1142-1147.
18. Walter K, Fulford AJ, McBeath R, Joseph S, Jones FM, et al. (2006) Increased human IgE induced by killing Schistosoma mansoni in vivo is associated with pretreatment Th2 cytokine responsiveness to worm antigens. J Immunol 177: 5490-5498.
19. Black CL, Muok EM, Mwinzi PN, Carter JM, Karanja DM, et al. (2010) Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni. J Infect Dis 202: 399-405.
20. Jiz M, Friedman JF, Leenstra T, Jarilla B, Pablo A, et al. (2009) Immunoglobulin E (IgE) responses to paramyosin predict resistance to reinfection with Schistosoma japonicum and are attenuated by IgG4. Infect Immun 77: 2051-2058.
21. Khalife J, Dunne DW, Richardson BA, Mazza G, Thorne KJ, et al. (1989) Functional role of human IgG subclasses in eosinophil-mediated killing of schistosomula of Schistosoma mansoni. J Immunol 142: 4422-4427.
22. Khalife J, Capron M, Capron A, Grzych JM, Butterworth AE, et al. (1986) Immunity in human schistosomiasis mansoni. Regulation of protective immune mechanisms by IgM blocking antibodies. J Exp Med 164: 1626-1640.
23. Butterworth AE, Bensted-Smith R, Capron A, Capron M, Dalton PR, et al. (1987) Immunity in human schistosomiasis mansoni: prevention by blocking antibodies of the expression of immunity in young children. Parasitology 94: 281-300.
24. Naus CW, Booth M, Jones FM, Kemijumbi J, Vennervald BJ, et al. (2003) The relationship between age, sex, egg-count and specific antibody responses against Schistosoma mansoni antigens in a Ugandan fishing community. Trop Med Int Health 8: 561-568.
25. Van Remoortere A, van Dam GJ, Hokke CH, van den Eijnden DH, van Die I, et al. (2001) Profiles of immunoglobulin M (IgM) and IgG antibodies against defined carbohydrate epitopes in sera of Schistosoma-infected individuals determined by surface plasmon resonance. Infect Immun 69: 2396-2401.
26. Eberl M, Langermans JA, Vervenne RA, Nyame AK, Cummings RD, et al. (2001) Antibodies to glycans dominate the host response to schistosome larvae and eggs: is their role protective or subversive? J Infect Dis 183: 1238-1247.
27. Kariuki TM, Farah IO, Wilson RA, Coulson PS, (2008) Antibodies elicited by the secretions from schistosome cercariae and eggs are predominantly against glycan epitopes. Parasite Immunol 30: 554-562.
28. Hokke CH, Deelder AM, (2001) Schistosome glycoconjugates in host-parasite interplay. Glycoconjugate J 18: 573-587.
29. Nyame AK, Lewis FA, Doughty BL, Correa-Oliveira R, Cummings RD, (2003) Immunity to schistosomiasis: glycans are potential antigenic targets for immune intervention. Exp Parasitol 104: 1-13.
30. Naus CW, Van Remoortere A, Ouma JH, Kimani G, Dunne DW, et al. (2003) Specific antibody responses to three schistosome-related carbohydrate structures in recently exposed immigrants and established residents in an area of Schistosoma mansoni endemicity. Infect Immun 71: 5676-5681.
31. Hokke CH, Deelder AM, Hoffmann KF, Wuhrer M, (2007) Glycomics-driven discoveries in schistosome research. Exp Parasitol 117: 275-283.
32. Hokke CH, Fitzpatrick JM, Hoffmann KF, (2007) Integrating transcriptome, proteome and glycome analyses of Schistosoma biology. Trends Parasitol 23: 165-174.
33. Hokke CH, Yazdanbakhsh M, (2005) Schistosome glycans and innate immunity. Parasite Immunol 27: 257-264.
34. Nyame AK, Kawar ZS, Cummings RD, (2004) Antigenic glycans in parasitic infections: implications for vaccines and diagnostics. Arch Biochem Biophys 426: 182-200.
35. De Boer AR, Hokke CH, Deelder AM, Wuhrer M, (2007) General microarray technique for immobilization and screening of natural glycans. Anal Chem 79: 8107-8113.
36. Lonardi E, Balog CI, Deelder AM, Wuhrer M, (2010) Natural glycan microarrays. Expert Rev Proteom 7: 761-774.
37. Blixt O, Head S, Mondala T, Scanlan C, Huflejt ME, et al. (2004) Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci USA 101: 17033-17038.
38. Bochner BS, Alvarez RA, Mehta P, Bovin NV, Blixt O, et al. (2005) Glycan array screening reveals a candidate ligand for Siglec-8. J Biol Chem 280: 4307-4312.
39. Smith DF, Song X, Cummings RD, (2010) Use of glycan microarrays to explore specificity of glycan-binding proteins. Methods Enzymol 480: 417-44: 417-444.
40. Bergwerff AA, van Dam GJ, Rotmans JP, Deelder AM, Kamerling JP, et al. (1994) The immunologically reactive part of immunopurified circulating anodic antigen from Schistosoma mansoni is a threonine-linked polysaccharide consisting of→6)-(beta-D-GlcpA-(1→3))-beta-D-GalpNAc-(1→repeating units. J Biol Chem 269: 31510-31517.
41. Vermeer HJ, Halkes KM, van Kuik JA, Kamerling JP, Vliegenthart JFG, (2000) Synthesis and conjugation of oligosaccharide fragments related to the immunologically reactive part of the circulating anodic antigen of the parasite Schistosoma mansoni. J Chem Soc Perkin Trans 1: 2249-2263.
42. Vermeer HJ, van Dam GJ, Halkes KM, Kamerling JP, Vliegenthart JF, et al. (2003) Immunodiagnostically applicable monoclonal antibodies to the circulating anodic antigen of Schistosoma mansoni bind to small, defined oligosaccharide epitopes. Parasitol Res 90: 330-336.
43. Van Roon AM, Aguilera B, Cuenca F, Van Remoortere A, van der Marel GA, et al. (2005) Synthesis and antibody-binding studies of a series of parasite fuco-oligosaccharides. Bioorgan Med Chem 13: 3553-3564.
44. De Boer AR, Hokke CH, Deelder AM, Wuhrer M, (2008) Serum antibody screening by surface plasmon resonance using a natural glycan microarray. Glycoconjugate J 25: 75-84.
45. Dunne DW, Vennervald BJ, Booth M, Joseph S, Fitzsimmons CM, et al. (2006) Applied and basic research on the epidemiology, morbidity, and immunology of schistosomiasis in fishing communities on Lake Albert, Uganda. Trans R Soc Trop Med Hyg 100: 216-223.
46. Kabatereine NB, Kemijumbi J, Ouma JH, Kariuki HC, Richter J, et al. (2004) Epidemiology and morbidity of Schistosoma mansoni infection in a fishing community along Lake Albert in Uganda. Trans R Soc Trop Med Hyg 98: 711-718.
47. Wuhrer M, Koeleman CA, Fitzpatrick JM, Hoffmann KF, Deelder AM, et al. (2006) Gender-specific expression of complex-type N-glycans in schistosomes. Glycobiology 16: 991-1006.
48. Oyelaran O, McShane LM, Dodd L, Gildersleeve JC, (2009) Profiling human serum antibodies with a carbohydrate antigen microarray. J Proteome Res 8: 4301-4310.
49. Hirakawa A, Sato Y, Hamada C, Yoshimura I, (2008) A new test statistic based on shrunken sample variance for identifying differentially expressed genes in small microarray experiments. Bioinformat Biol Insights 2: 145-156.
50. Kabatereine NB, Vennervald BJ, Ouma JH, Kemijumbi J, Butterworth AE, et al. (1999) Adult resistance to schistosomiasis mansoni: age-dependence of reinfection remains constant in communities with diverse exposure patterns. Parasitology 118: 101-105.
51. Van Remoortere A, Vermeer HJ, van Roon AM, Langermans JA, Thomas AW, et al. (2003) Dominant antibody responses to Fucalpha1-3GalNAc and Fucalpha1-2Fucalpha1-3GlcNAc containing carbohydrate epitopes in Pan troglodytes vaccinated and infected with Schistosoma mansoni. Exp Parasitol 105: 219-225.
52. Van der Kleij D, Tielens AG, Yazdanbakhsh M, (1999) Recognition of schistosome glycolipids by immunoglobulin E: possible role in immunity. Infect Immun 67: 5946-5950.
53. Khoo KH, Huang HH, Lee KM, (2001) Characteristic structural features of schistosome cercarial N-glycans: expression of Lewis X and core xylosylation. Glycobiology 11: 149-163.
54. Wuhrer M, Dennis RD, Doenhoff MJ, Lochnit G, Geyer R, (2000) Schistosoma mansoni cercarial glycolipids are dominated by Lewis X and pseudo-Lewis Y structures. Glycobiology 10: 89-101.